Status:
UNKNOWN
AntiDFS70 Lupus Nephritis
Lead Sponsor:
Sohag University
Conditions:
Systemic Lupus Erythematosus
Eligibility:
All Genders
18-70 years
Brief Summary
Systemic lupus erythematous (SLE) is a heterogeneous autoimmune disease that involve many different organs and display a variable clinical course. The prevalence of SLE varies across gender, race/ethn...
Eligibility Criteria
Inclusion
- Patients who fulfill the 2019 American College of Rheumatology/European League against Rheumatism classification criteria of Systemic Lupus Erythematous . (9)
- Patients who is able to give informed consent to join the study.
- •
Exclusion
- \-
- \- Any patient with any collagen disease other than systemic lupus erythematous
Key Trial Info
Start Date :
October 15 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 25 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06119763
Start Date
October 15 2023
End Date
October 25 2024
Last Update
November 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag university Hospital
Sohag, Egypt, Sohag